Full text is available at the source.
Abstract
Retatrutide is a triple-receptor agonist of three key hormones related to glucose regulation.
- It targets glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptors.
- This mechanism suggests potential roles in managing blood sugar levels.
- The interaction with these receptors may influence metabolic processes.
- Further investigation is needed to understand its full effects on glucose homeostasis.
Simplified
GLP-1 Therapies